共 33 条
SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53
被引:155
作者:
Kim, Duk Hoon
[1
]
Jung, Yu Jin
[1
]
Lee, Jung Eun
[1
]
Lee, Ae Sin
[1
]
Kang, Kyung Pyo
[1
,4
]
Lee, Sik
[1
,4
]
Park, Sung Kwang
[1
,4
]
Han, Myung Kwan
[2
]
Lee, Sang Yong
[3
]
Ramkumar, Kunga Mohan
[1
]
Sung, Mi Jeong
[5
]
Kim, Won
[1
,4
]
机构:
[1] Chonbuk Natl Univ, Sch Med, Dept Internal Med, Jeonju 560180, South Korea
[2] Chonbuk Natl Univ, Sch Med, Dept Microbiol, Jeonju 560180, South Korea
[3] Chonbuk Natl Univ, Sch Med, Dept Diagnost Radiol, Jeonju 560180, South Korea
[4] Chonbuk Natl Univ, Sch Med, Inst Med Sci, Jeonju 560180, South Korea
[5] Korea Food Res Inst, Food Funct Res Div, Songnam, South Korea
关键词:
apoptosis;
cisplatin nephrotoxicity;
ACUTE KIDNEY INJURY;
NF-KAPPA-B;
TRAIL-INDUCED APOPTOSIS;
HISTONE DEACETYLASE;
CELL APOPTOSIS;
ACETYLATION;
INHIBITORS;
PROTECTS;
ALPHA;
SENSITIZATION;
D O I:
10.1152/ajprenal.00258.2010
中图分类号:
Q4 [生理学];
学科分类号:
071003 ;
摘要:
Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK, Han MK, Lee SY, Ramkumar KM, Sung MJ, Kim W. SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol 301: F427-F435, 2011. First published May 18, 2011; doi: 10.1152/ajprenal.00258.2010.-Nephrotoxicity is one of the important dose-limiting factors during cisplatin treatment. There is a growing body of evidence that activation of p53 has a critical role in cisplatin-induced renal apoptotic injury. The nicotinamide adenine dinucleotide-dependent protein deacetylase SIRT1 decreases apoptosis through deacetylating of p53, and resveratrol is known as an activator of SIRT1. To study the role of SIRT1 in cisplatin-induced renal injury through interaction with p53, mouse proximal tubular cells (MPT) were treated with cisplatin and examined the expression level of SIRT1, acetylation of p53, PUMA-alpha, Bax, the cytosolic/mitochondrial cytochrome c ratio, and active caspase-3. The expression of SIRT1 was decreased by cisplatin. Resveratrol, a SIRT1 activator, ameliorated cisplatin-induced acetylation of p53, apoptosis, and cytotoxicity in MPT cells. In addition, resveratrol remarkably blocked cisplatin-induced decrease of Bcl-xL in MPT cells. Further specific SIRT1 inhibition with EX 527 or small interference RNA specific to SIRT1 reversed the effect of resveratrol on cisplatin-induced toxicity. Inhibition of p53 by pifithrin-alpha reversed the effect of EX527 in protein expression of PUMA-alpha, Bcl-xL, and caspase-3 and cytotoxicity in MPT cells. SIRT1 protein expression after cisplatin treatment was significantly decreased in the kidney. SIRT1 activation by resveratrol decreased cisplatin-induced apoptosis while improving the glomerular filtration rate. Taken together, our findings suggest that the modulation of p53 by SIRT1 could be a possible target to attenuate cisplatin-induced kidney injury.
引用
收藏
页码:F427 / F435
页数:9
相关论文